Palantir (PLTR) CFO Executes 10b5-1 Plan: Option Exercise and Significant Stock Sales
Rhea-AI Filing Summary
Palantir (PLTR) Chief Financial Officer David A. Glazer reported multiple transactions on September 2, 2025, executed under a preexisting Rule 10b5-1 trading plan.
The reporting person exercised an aggregate of 37,770 vested stock options (26,513 and 11,257) with an exercise price of $4.72 and immediately sold those shares along with 43,230 additional shares in open-market trades on the same date. The reported sales were executed across price ranges from $150.42 to $158.11, with several weighted-average prices shown for different tranches. The filings show the reporting person owned 500,912 shares before the series of transactions and 431,169 shares following the reported sales.
Positive
- Transactions executed pursuant to a preexisting Rule 10b5-1 trading plan, providing an affirmative defense and signaling preplanned activity
- Exercised options were fully vested, as explicitly stated in the filing
- Filing includes detailed footnotes with price-range disclosures and an offer to provide tranche-level sale details upon request
Negative
- Substantial insider selling: an aggregate of 81,000 shares were sold on September 2, 2025, reducing beneficial ownership from 500,912 to 431,169 shares
- Material reduction in holdings by CFO could be perceived as noteworthy by investors given the size of the sales
Insights
Insider exercised vested options and sold a meaningful block under a 10b5-1 plan; transactions appear procedural rather than unusual.
The Form 4 discloses that the CFO exercised 37,770 fully vested employee stock options at $4.72 and sold those shares plus 43,230 additional shares in multiple open-market trades on September 2, 2025, resulting in reported proceeds across price bands of roughly $150 to $158 per share. The use of a preexisting Rule 10b5-1 plan (entered June 3, 2025) is explicitly noted, which provides an affirmative defense for trades executed pursuant to a predetermined schedule. The filing quantifies the post-transaction beneficial ownership decline from 500,912 to 431,169 shares, and indicates 223,487 options remain reported in Table II after these exercises. For investors, this is a clear disclosure of option exercise and substantial selling by a senior officer, documented as plan-driven rather than ad hoc.
Disclosure aligns with Section 16 reporting norms; 10b5-1 plan use and explicit footnotes improve transparency.
The Form 4 includes detailed footnotes describing price ranges for multiple tranches of open-market sales and affirms that the exercised options were fully vested as of the transaction date. The reporting person also commits to provide detailed trade-by-trade pricing to SEC staff or shareholders upon request, which enhances disclosure quality. The filing includes the officer's title (Chief Financial Officer and Treasurer) and a cross-reference to the proxy statement for fuller ownership context. From a governance perspective, these elements support compliance and transparency while documenting a material reduction in beneficial holdings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 11,257 | $0.00 | -- |
| Exercise | Employee Stock Option (Right to buy) | 26,513 | $0.00 | -- |
| Exercise | Class A Common Stock | 26,513 | $4.72 | $125K |
| Exercise | Class A Common Stock | 11,257 | $4.72 | $53K |
| Sale | Class A Common Stock | 200 | $150.85 | $30K |
| Sale | Class A Common Stock | 27,500 | $152.1807 | $4.18M |
| Sale | Class A Common Stock | 700 | $153.2229 | $107K |
| Sale | Class A Common Stock | 500 | $154.322 | $77K |
| Sale | Class A Common Stock | 38,500 | $155.2068 | $5.98M |
| Sale | Class A Common Stock | 4,631 | $156.5673 | $725K |
| Sale | Class A Common Stock | 8,569 | $157.3661 | $1.35M |
| Sale | Class A Common Stock | 400 | $158.0775 | $63K |
Footnotes (1)
- This transaction is part of a related series of transactions undertaken on September 2, 2025 pursuant to a preexisting Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on June 3, 2025. The Reporting Person exercised an aggregate of 37,770 vested Class A Common Stock options and immediately sold the shares of Class A Common Stock along with 43,230 additional shares of Class A Common Stock in the open market. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $150.42 to $151.28. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $151.84 to $152.47. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $152.91 to $153.71. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $153.99 to $154.64. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $155.01 to $155.98. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $156.02 to $157.00. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $157.02 to $158.00. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $158.02 to $158.11. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The options exercised in this transaction were fully vested and exercisable as of the transaction date.
